Summit Trail Advisors, LLC Novartis Ag Transaction History

Summit Trail Advisors, LLC

  • $7.06 Billion
  • Q3 2025

A detailed history of Summit Trail Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 7,057 shares of NVS stock, worth $928,348. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,057
Previous 6,557 7.63%
Holding current value
$928,348
Previous $793,000 14.0%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$113.5 - $129.73 $56,750 - $64,864
500 Added 7.63%
7,057 $904,000
Q2 2025

Aug 14, 2025
BUY
$101.96 - $121.01 $20,086 - $23,838
197 Added 3.1%
6,557 $793,000
Q1 2025

Apr 28, 2025
BUY
$97.14 - $115.57 $56,341 - $67,030
580 Added 10.03%
6,360 $709,000
Q4 2024

Jan 29, 2025
BUY
$96.78 - $117.18 $58,358 - $70,659
603 Added 11.65%
5,780 $562,000
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $39,904 - $45,454
-376 Reduced 6.77%
5,177 $595,000
Q2 2024

Aug 13, 2024
BUY
$92.57 - $107.37 $88,496 - $102,645
956 Added 20.8%
5,553 $591,000
Q1 2024

Apr 23, 2024
BUY
$95.27 - $108.47 $26,103 - $29,720
274 Added 6.34%
4,597 $444,000
Q4 2023

Feb 06, 2024
BUY
$92.27 - $101.54 $63,204 - $69,554
685 Added 18.83%
4,323 $436,000
Q3 2023

Oct 30, 2023
SELL
$94.73 - $105.13 $59,016 - $65,495
-623 Reduced 14.62%
3,638 $370,000
Q2 2023

Jul 25, 2023
BUY
$92.52 - $104.91 $66,244 - $75,115
716 Added 20.2%
4,261 $429,000
Q1 2023

May 04, 2023
BUY
$80.03 - $92.81 $283,706 - $329,011
3,545 New
3,545 $326,000
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $275,978 - $312,185
-3,445 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$79.7 - $88.13 $274,566 - $303,607
3,445 New
3,445 $301,000
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $312,907 - $348,420
-4,248 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $46,054 - $53,271
688 Added 19.33%
4,248 $366,000
Q2 2018

Aug 10, 2018
SELL
$64.91 - $73.36 $1.26 Million - $1.43 Million
-19,460 Reduced 84.54%
3,560 $269,000
Q1 2018

May 22, 2018
SELL
$70.39 - $84.15 $103 Million - $123 Million
-1,460,058 Reduced 98.45%
23,020 $1.48 Million
Q1 2018

May 21, 2018
BUY
$70.39 - $84.15 $103 Million - $123 Million
1,464,531 Added 7896.32%
1,483,078 $1.48 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $1.34 Million - $1.44 Million
18,547
18,547 $1.68 Million

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email